FPR2-selective peptidomimetics derived from Annexin A1—CR-AnxA12–50 and CR-AnxA12–48—have each conferred robust protection against acute myocardial ischemia–reperfusion (I/R) injury in murine models [124,125]. This evidence concerns the gene ANXA1 and myocardial ischemia.